VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRCA is currently covered by 5 analysts with an average price target of $12.01. This is a potential upside of $6.44 (115.62%) from yesterday's end of day stock price of $5.57.

Verrica Pharmaceuticals's activity chart (see below) currently has 49 price targets and 56 ratings on display. The stock rating distribution of VRCA is 59.09% BUY and 40.91% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.99% with an average time for these price targets to be met of 88.43 days.

Highest price target for VRCA is $3, Lowest price target is $2, average price target is $2.5.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 14-May-2025. First documented stock forecast 21-Feb-2019.

Currently out of the existing stock ratings of VRCA, 13 are a BUY (59.09%), 9 are a HOLD (40.91%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 months 22 days ago
(14-May-2025)

3/9 (33.33%)

$9.09 (312.37%)

169

Hold

3 months 28 days ago
(08-Apr-2025)

0/13 (0%)

$4.51 (47.52%)

Buy

$3

$-2.63 (-46.71%)

$12

6 months 30 days ago
(06-Jan-2025)

1/4 (25%)

$2.33 (347.76%)

200

Hold

$2

$-3.63 (-64.48%)

9 months ago
(05-Nov-2024)

2/7 (28.57%)

$1.2 (150.00%)

171

Hold

$20

10 months 3 days ago
(02-Oct-2024)

0/1 (0%)

$12.04 (151.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 88.43 days on average for the stock forecasts to be realized with a an average price target met ratio 15.99

Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

SERGE BELANGER

Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Serge Belanger works at NEEDHAM and has 4 price targets and 7 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Tim Chiang with highest potential upside - $15.41

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Gregory Renza with lowest potential downside - -$3.63

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?